TrademarkDir
BIOCUT
LIVE

Serial Number

87793871

Owner

BioCut, LLC

Attorney

John Osmanski

First Use Date

Oct 13, 2016

Filing Date

Feb 12, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BIOCUT Trademark

Serial Number: 87793871 • Registration: 6036065

BIOCUT is a trademark filed by BioCut, LLC on February 12, 2018. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

BioCut, LLC (15 trademarks)

8219 W. Bradley Rd
Milwaukee, WI 53223

Entity Type: 16

Trademark Details

Filing Date

February 12, 2018

Registration Date

April 21, 2020

First Use Anywhere

October 13, 2016

First Use in Commerce

October 13, 2016

Published for Opposition

February 4, 2020

Goods & Services

Dies for cutting tissue samples used with hydraulic and pneumatic machine presses specifically designed for use in volume processing of tissue grafts for medical treatment use in the field of regenerative medicine

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 24, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 24, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 24, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 6, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 21, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 4, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 4, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 15, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 27, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 4, 2019 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jul 22, 2019 GNS1
SUBSEQUENT FINAL EMAILED
Jul 22, 2019 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Jul 22, 2019 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 14, 2019 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
May 9, 2019 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
May 9, 2019 GNCF
ACTION CONTINUING A FINAL - COMPLETED
May 9, 2019 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 8, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 27, 2019 GNFN
FINAL REFUSAL E-MAILED
Feb 27, 2019 GNFR
FINAL REFUSAL WRITTEN
Feb 27, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 7, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 7, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 7, 2019 CNRT
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 26, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 26, 2018 GNSL
SUSPENSION LETTER WRITTEN
Jun 26, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 13, 2018 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2018 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jun 4, 2018 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jun 4, 2018 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Jun 4, 2018 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jun 4, 2018 CPEA
ASSIGNED TO LIE
Jun 1, 2018 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
May 29, 2018 PARI
ASSIGNED TO EXAMINER
May 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 20, 2018 NWOS
NEW APPLICATION ENTERED
Feb 15, 2018 NWAP

Related Trademarks

More from this Owner

ARES

ARES

ATHENA

ATHENA

ATHENA

ATHENA

ATHENA

ATHENA

DISRUPT. CREATE. ADVANCE.

DISRUPT. CREATE. ADVANCE.

DISRUPT. CREATE. ADVANCE.

DISRUPT. CREATE. ADVANCE.